During the past decade, Affiliated Hospital of Jiangsu University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Jiangsu University" are "Chronic HCV Infection" (1 trials), "Erosive Esophagitis" (1 trials), "Gastroesophageal Reflux Disease" (1 trials), "Heartburn" (1 trials) and "Multidrug Resistant Tuberculosis" (1 trials). Many other conditions were trialed in "Affiliated Hospital of Jiangsu University" in a lesser frequency.

Most popular intervention types in "Affiliated Hospital of Jiangsu University" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Dexlansoprazole" (2 trials), "Placebo" (2 trials), "DAG181" (1 trials), "Lansoprazole" (1 trials) and "Pyrazinamide containing regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Hospital of Jiangsu University" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Affiliated Hospital of Jiangsu University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Affiliated Hospital of Jiangsu University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Hospital of Jiangsu University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".